Variant report
Variant | esv3376356 |
---|---|
Chromosome Location | chr6:167582508-167583070 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:167582908-167582917 | GM19239 | blood: | n/a | n/a |
2 | CTCF | chr6:167582989-167583038 | GM12892 | blood: | n/a | n/a |
3 | POLR2A | chr6:167582820-167582988 | HepG2 | liver: | n/a | n/a |
4 | POLR2A | chr6:167582908-167583179 | MCF-7 | breast: | n/a | n/a |
5 | POLR2A | chr6:167582937-167582939 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr6:167583008-167583029 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr6:167583030-167583187 | MCF-7 | breast: | n/a | n/a |
8 | POU2F2 | chr6:167582726-167583180 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPR31-3 | chr6:167583039-167583124 | FPKM1_group_28907_transcript_1 |
2 | lnc-GPR31-3 | chr6:167582786-167583124 | NONHSAT116085 |
3 | lnc-GPR31-3 | chr6:167582786-167583034 | FPKM1_group_28907_transcript_1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TCP10L2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541150404 | chr6:167582528-167582529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374292818 | chr6:167582557-167582558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191276207 | chr6:167582559-167582560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530086933 | chr6:167582570-167582571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368619860 | chr6:167582573-167582574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142983499 | chr6:167582613-167582614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200854758 | chr6:167582621-167582622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs151107619 | chr6:167582624-167582625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377416670 | chr6:167582641-167582642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3117543 | chr6:167582642-167582643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548613456 | chr6:167582661-167582662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563715126 | chr6:167582670-167582671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531503556 | chr6:167582721-167582722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372904994 | chr6:167582760-167582761 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs550078432 | chr6:167582762-167582763 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs374878887 | chr6:167582771-167582772 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs369230770 | chr6:167582799-167582800 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs538845432 | chr6:167582805-167582806 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs547062889 | chr6:167582827-167582828 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs111210810 | chr6:167582920-167582921 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs145084172 | chr6:167582929-167582930 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs201550103 | chr6:167582938-167582939 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs111066659 | chr6:167582946-167582947 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs565442897 | chr6:167582983-167582984 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs535803298 | chr6:167582997-167582998 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs554132861 | chr6:167583001-167583002 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs575676981 | chr6:167583052-167583053 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Developmental delay | 21147756 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167579200-167586200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:167579200-167587600 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr6:167579400-167582800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr6:167582800-167583200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr6:167582800-167583200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr6:167582800-167583200 | Bivalent/Poised TSS | Fetal Kidney | kidney |
7 | chr6:167582800-167583400 | Enhancers | Gastric | stomach |
8 | chr6:167582800-167583400 | Enhancers | Pancreas | Pancrea |
9 | chr6:167583000-167583400 | Enhancers | Primary B cells from peripheral blood | blood |